Annual report pursuant to Section 13 and 15(d)

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.8.0.1
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2017
Antidilutive securities excluded from computation of earnings per share
We did not include the following securities in the table below in the computation of diluted net loss per common share because the securities were anti-dilutive during the periods presented:
 
 
 
 
For the year ended
December 31,
 
 
 
2017
 
2016
 
 
 
 
 
 
 
 
 
Warrants
 
 
2,934,685
 
 
3,736,617
 
Stock options
 
 
5,429,727
 
 
4,771,560
 
Total
 
 
8,364,412
 
 
8,508,177
 
Employee Stock Option [Member]  
Stock-based compensation allocation
The following table summarizes stock based option compensation for the years ended December 31, 2017 and 2016 which was allocated as follows (in thousands):
 
 
 
Year ended
December 31, 2017
 
Year ended
December 31, 2016
 
Research and development
 
$
1,668
 
$
1,219
 
General and administrative
 
 
2,976
 
 
3,610
 
Stock based compensation expense included in operating expense
 
 
4,644
 
 
4,829
 
 
 
 
 
 
 
 
 
Total stock based compensation expense
 
 
4,644
 
 
4,829
 
Tax benefit
 
 
-
 
 
-
 
Stock based compensation expense, net of tax
 
$
4,644
 
$
4,829
 
Restricted Stock [Member]  
Stock-based compensation allocation
The following table summarizes restricted stock compensation for the years ended December 31, 2017 and 2016 which was allocated as follows (in thousands):
 
 
 
Year ended
December 31, 2017
 
Year ended
December 31, 2016
 
Research and development
 
$
-
 
$
200
 
General and administrative
 
 
1,272
 
 
3,232
 
Stock based compensation expense included in operating expense
 
 
1,272
 
 
3,432
 
 
 
 
 
 
 
 
 
Total stock based compensation expense
 
 
1,272
 
 
3,432
 
Tax benefit
 
 
-
 
 
-
 
Stock based compensation expense, net of tax
 
$
1,272
 
$
3,432